The DOI matches its Crossref record; 800 of the 800 references it cites were found in a registry or an index.
Pulmonary Arterial Hypertension
Abstract
ost practicing cardiologists see patients with pulmo- nary hypertension (PH) on a regular basis.Although this is most commonly in the form of pulmonary venous hypertension related to elevated left heart pressures, the explosion in knowledge of and treatment for pulmonary arterial hypertension (PAH) over the past decade obligates cardiologists to be more cognizant of this disorder.In this review, we will discuss the pathobiology, classification, diagnosis, and treatment of PAH in adults.The term PAH in this context refers specifically to a pulmonary hypertensive state limited predominantly to the arterial component of the pulmonary vasculature and constitutes one of the main classifications of clinical PH diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 800
McDonald, K. K., Zharikov, S., Block, E. R., & Kilberg, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31213 · Cited by 436
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J.-M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C. G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
A USA-based registry for pulmonary arterial hypertension: 1982–2006
Thenappan, T., Shah, S. J., Rich, S., & Gomberg-Maitland, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00042107 · Cited by 432
Lee, S. D., Shroyer, K. R., Markham, N. E., Cool, C. D., Voelkel, N. F., & Tuder, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1910 · Cited by 428
Kawut, S. M., Taichman, D. B., Archer-Chicko, C. L., Palevsky, H. I., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.123.2.344 · Cited by 427
Vasodilator Therapy for Primary Pulmonary Hypertension in Children
Barst, R. J., Maislin, G., & Fishman, A. P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1197 · Cited by 427
Gender, age, and heart failure with preserved left ventricular systolic function
Masoudi, F. A., Havranek, E. P., Smith, G., Fish, R. H., Steiner, J. F., Ordin, D. L., & Krumholz, H. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02696-7 · Cited by 426
Yuan, J. X.-J., Aldinger, A. M., Juhaszova, M., Wang, J., Conte, J. V., Gaine, S. P., Orens, J. B., & Rubin, L. J. (1998) · Circulation · doi:10.1161/01.cir.98.14.1400 · Cited by 425
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis
Nunes, H. (2005) · Thorax · doi:10.1136/thx.2005.042838 · Cited by 420
Epidemiology of Diastolic Heart Failure
Owan, T. E., & Redfield, M. M. (2005) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.02.010 · Cited by 420
Mahapatra, S., Nishimura, R. A., Sorajja, P., Cha, S., & McGoon, M. D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.054 · Cited by 416
Self-citationCostard-Jäckle, A., & Fowler, M. B. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90050-w · Cited by 415
Impact of Pulmonary Hypertension on the Outcomes of Noncardiac Surgery
Ramakrishna, G., Sprung, J., Ravi, B. S., Chandrasekaran, K., & McGoon, M. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.055 · Cited by 413
Self-citationJego, P. (1996) · La Revue de Médecine Interne · doi:10.1016/0248-8663(96)83752-0 · Cited by 409
Fijalkowska, A., Kurzyna, M., Torbicki, A., Szewczyk, G., Florczyk, M., Pruszczyk, P., & Szturmowicz, M. (2006) · Chest · doi:10.1378/chest.129.5.1313 · Cited by 407
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
Machado, R. D., Aldred, M. A., James, V., Harrison, R. E., Patel, B., Schwalbe, E. C., Gruenig, E., Janssen, B., Koehler, R., Seeger, W., et al. (2006) · Human Mutation · doi:10.1002/humu.20285 · Cited by 402
Abe, K., Shimokawa, H., Morikawa, K., Uwatoku, T., Oi, K., Matsumoto, Y., Hattori, T., Nakashima, Y., Kaibuchi, K., Sueishi, K., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000111804.34509.94 · Cited by 402
Moraes, D. L., Colucci, W. S., & Givertz, M. M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1718 · Cited by 401
Signaling Molecules in Nonfamilial Pulmonary Hypertension
Du, L., Sullivan, C. C., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Yuan, J. X.-J., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021650 · Cited by 400
Primary pulmonary hypertension
Dresdale, D. T., Schultz, M., & Michtom, R. J. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90020-4 · Cited by 399
Inhaled Nitric Oxide Therapy in Adults
Griffiths, M. J. D., & Evans, T. W. (2005) · New England Journal of Medicine · doi:10.1056/nejmra051884 · Cited by 398
Alterations of cellular bioenergetics in pulmonary artery endothelial cells
Xu, W., Koeck, T., Lara, A. R., Neumann, D., DiFilippo, F. P., Koo, M., Janocha, A. J., Masri, F. A., Arroliga, A. C., Jennings, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605080104 · Cited by 395
Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension
Wilkens, H., Guth, A., König, J., Forestier, N., Cremers, B., Hennen, B., Böhm, M., & Sybrecht, G. W. (2001) · Circulation · doi:10.1161/hc3601.096826 · Cited by 392
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391
Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype
Topper, J. N., & Gimbrone Jr, M. A. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01372-0 · Cited by 390
Rubens, C., Ewert, R., Halank, M., Wensel, R., Orzechowski, H.-D., Schultheiss, H.-P., & Hoeffken, G. (2001) · Chest · doi:10.1378/chest.120.5.1562 · Cited by 388
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 387
Portopulmonary hypertension: Results from a 10-year screening algorithm
Krowka, M. J., Swanson, K. L., Frantz, R. P., McGoon, M. D., & Wiesner, R. H. (2006) · Hepatology · doi:10.1002/hep.21431 · Cited by 385
Self-citationSildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats
Zhang, R., Wang, Y., Zhang, L., Zhang, Z., Tsang, W., Lu, M., Zhang, L., & Chopp, M. (2002) · Stroke · doi:10.1161/01.str.0000034399.95249.59 · Cited by 383
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
Koh, K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00146-2 · Cited by 380
Laufs, U., Marra, D., Node, K., & Liao, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21926 · Cited by 380
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study
Wilkins, M. R., Paul, G. A., Strange, J. W., Tunariu, N., Gin-Sing, W., Banya, W. A., Westwood, M. A., Stefanidis, A., Ng, L. L., Pennell, D. J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1411oc · Cited by 380
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
Cowan, K. N., Heilbut, A., Humpl, T., Lam, C., Ito, S., & Rabinovitch, M. (2000) · Nature Medicine · doi:10.1038/76282 · Cited by 378
Galiè, N., Hinderliter, A. L., Torbicki, A., Fourme, T., Simonneau, G., Pulido, T., Espinola-Zavaleta, N., Rocchi, G., Manes, A., Frantz, R., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00121-9 · Cited by 378
Masri, F. A., Xu, W., Comhair, S. A. A., Asosingh, K., Koo, M., Vasanji, A., Drazba, J., Anand-Apte, B., & Erzurum, S. C. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00428.2006 · Cited by 376
Mukerjee, D. (2004) · Rheumatology · doi:10.1093/rheumatology/keh067 · Cited by 376
Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms
McQuillan, L. P., Leung, G. K., Marsden, P. A., Kostyk, S. K., & Kourembanas, S. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.5.h1921 · Cited by 375
Rich, S., Seidlitz, M., Dodin, E., Osimani, D., Judd, D., Genthner, D., McLaughlin, V., & Francis, G. (1998) · Chest · doi:10.1378/chest.114.3.787 · Cited by 371
Self-citationAntiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
Wharton, J., Strange, J. W., Møller, G. M. O., Growcott, E. J., Ren, X., Franklyn, A. P., Phillips, S. C., & Wilkins, M. R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1587oc · Cited by 371
Nitrate Therapy for Stable Angina Pectoris
Parker, J. D., & Parker, J. O. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380807 · Cited by 371
Michelakis, E. D., McMurtry, M. S., Wu, X.-C., Dyck, J. R. B., Moudgil, R., Hopkins, T. A., Lopaschuk, G. D., Puttagunta, L., Waite, R., & Archer, S. L. (2002) · Circulation · doi:10.1161/hc0202.101974 · Cited by 369
McMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 368
Archer, S. L., Gomberg-Maitland, M., Maitland, M. L., Rich, S., Garcia, J. G. N., & Weir, E. K. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01324.2007 · Cited by 366
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
Sandoval, J., Bauerle, O., Palomar, A., Gómez, A., Martínez-Guerra, M. L., Beltrán, M., & Guerrero, M. L. (1994) · Circulation · doi:10.1161/01.cir.89.4.1733 · Cited by 366
Hansmann, G., Wagner, R. A., Schellong, S., de Jesus Perez, V. A., Urashima, T., Wang, L., Sheikh, A. Y., Suen, R. S., Stewart, D. J., & Rabinovitch, M. (2007) · Circulation · doi:10.1161/circulationaha.106.663120 · Cited by 366
Ghofrani, H. A., Rose, F., Schermuly, R. T., Olschewski, H., Wiedemann, R., Kreckel, A., Weissmann, N., Ghofrani, S., Enke, B., Seeger, W., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00555-2 · Cited by 365
Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension
Sanchez, O., Sitbon, O., Jaïs, X., Simonneau, G., & Humbert, M. (2006) · Chest · doi:10.1378/chest.130.1.182 · Cited by 363
Harrison, R. E., Flanagan, J. A., Sankelo, M., Abdalla, S. A., Rowell, J., Machado, R. D., Elliott, C. G., Robbins, I. M., Olschewski, H., McLaughlin, V, et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.12.865 · Cited by 362
Self-citationNishimura, R. A., Appleton, C. P., Redfield, M. M., Ilstrup, D. M., Holmes, D. R., & Tajik, A. J. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00315-4 · Cited by 360
Pulmonary vascular disorders in portal hypertension
Herve, P., Lebrec, D., Brenot, F., Simonneau, G., Humbert, M., Sitbon, O., & Duroux, P. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11051153 · Cited by 360
Johnson, L. N., & Arnold, A. C. (1994) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-199403000-00011 · Cited by 359
Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A
Fawcett, L., Baxendale, R., Stacey, P., McGrouther, C., Harrow, I., Soderling, S., Hetman, J., Beavo, J. A., & Phillips, S. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3702 · Cited by 359
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension
Sandoval, J., Gaspar, J., Pulido, T., Bautista, E., Martínez-Guerra, M. L., Zeballos, M., Palomar, A., & Gómez, A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00238-1 · Cited by 356
Shi-Wen, X., Chen, Y., Denton, C. P., Eastwood, M., Renzoni, E. A., Bou-Gharios, G., Pearson, J. D., Dashwood, M., du Bois, R. M., Black, C. M., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0902 · Cited by 356
Fisher, P. W., Salloum, F., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 355
Primary Pulmonary Hypertension: A Vascular Biology and Translational Research “Work in Progress”
Archer, S., & Rich, S. (2000) · Circulation · doi:10.1161/01.cir.102.22.2781 · Cited by 354
Colle, I. O., Moreau, R., Godinho, E., Belghiti, J., Ettori, F., Cohen-Solal, A., Mal, H., Bernuau, J., Marty, J., Lebrec, D., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50060 · Cited by 354
Primary Pulmonary Hypertension in HIV Infection
Speich, R., Jenni, R., Opravil, M., Pfab, M., & Russi, E. W. (1991) · Chest · doi:10.1378/chest.100.5.1268 · Cited by 354
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
Petkov, V., Mosgoeller, W., Ziesche, R., Raderer, M., Stiebellehner, L., Vonbank, K., Funk, G.-C., Hamilton, G., Novotny, C., Burian, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17500 · Cited by 352
Barst, R. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00005-5 · Cited by 350
Jones, P. L., Crack, J., & Rabinovitch, M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.279 · Cited by 350
Dorfmüller, P., Humbert, M., Perros, F., Sanchez, O., Simonneau, G., Müller, K.-M., & Capron, F. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.022 · Cited by 341
Health-related quality of life is related to COPD disease severity
Ståhl, E., Lindberg, A., Jansson, S.-A., Rönmark, E., Svensson, K., Andersson, F., Löfdahl, C.-G., & Lundbäck, B. (2005) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-3-56 · Cited by 340
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
Barst, R. J., Galie, N., Naeije, R., Simonneau, G., Jeffs, R., Arneson, C., & Rubin, L. J. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00044406 · Cited by 338
Relaxation and diastole of the heart
Brutsaert, D. L., & Sys, S. U. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.4.1228 · Cited by 338
Guidelines for good pharmacoepidemiology practices (GPP)
ISPE (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1471 · Cited by 337
Haemodynamic evaluation of pulmonary hypertension
Chemla, D., Castelain, V., Hervé, P., Lecarpentier, Y., & Brimioulle, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00068002 · Cited by 337
PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression
Yu, Y., Sweeney, M., Zhang, S., Platoshyn, O., Landsberg, J., Rothman, A., & Yuan, J. X.-J. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00125.2002 · Cited by 337
Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy
Fries, R., Shariat, K., von Wilmowsky, H., & Böhm, M. (2005) · Circulation · doi:10.1161/circulationaha.104.523324 · Cited by 337
Sildenafil in Primary Pulmonary Hypertension
Prasad, S., Wilkinson, J., & Gatzoulis, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431814 · Cited by 337
Outcomes in heart failure patients with preserved ejection fraction
Smith, G. L., Masoudi, F. A., Vaccarino, V., Radford, M. J., & Krumholz, H. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00185-2 · Cited by 335
Yoshibayashi, M., Nishioka, K., Nakao, K., Saito, Y., Matsumura, M., Ueda, T., Temma, S., Shirakami, G., Imura, H., & Mikawa, H. (1991) · Circulation · doi:10.1161/01.cir.84.6.2280 · Cited by 332
Oka, M., Homma, N., Taraseviciene-Stewart, L., Morris, K. G., Kraskauskas, D., Burns, N., Voelkel, N. F., & McMurtry, I. F. (2007) · Circulation Research · doi:10.1161/01.res.0000261658.12024.18 · Cited by 331
Teichert-Kuliszewska, K., Kutryk, M. J. B., Kuliszewski, M. A., Karoubi, G., Courtman, D. W., Zucco, L., Granton, J., & Stewart, D. J. (2006) · Circulation Research · doi:10.1161/01.res.0000200180.01710.e6 · Cited by 331
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro, O., Hoque, M., & Brown, B. D. (2003) · Blood · doi:10.1182/blood-2002-03-0948 · Cited by 327
HIV-Related Pulmonary Hypertension
Mehta, N. J., Khan, I. A., Mehta, R. N., & Sepkowitz, D. A. (2000) · Chest · doi:10.1378/chest.118.4.1133 · Cited by 325
Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1
Foletta, V. C., Lim, M. A., Soosairajah, J., Kelly, A. P., Stanley, E. G., Shannon, M., He, W., Das, S., Massagué, J., & Bernard, O. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212060 · Cited by 325
Denton, C. P., Cailes, J. B., Phillips, G. D., Wells, A. U., Black, C. M., & Bois, R. M. (1997) · Rheumatology · doi:10.1093/rheumatology/36.2.239 · Cited by 323
Wang, X.-X., Zhang, F.-R., Shang, Y.-P., Zhu, J.-H., Xie, X.-D., Tao, Q.-M., Zhu, J.-H., & Chen, J.-Z. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.037 · Cited by 322
Bonnin, M., Mercier, F. J., Sitbon, O., Roger-Christoph, S., Jaïs, X., Humbert, M., Audibert, F., Frydman, R., Simonneau, G., & Benhamou, D. (2005) · Anesthesiology · doi:10.1097/00000542-200506000-00012 · Cited by 322
Maurice, D. H., Palmer, D., Tilley, D. G., Dunkerley, H. A., Netherton, S. J., Raymond, D. R., Elbatarny, H. S., & Jimmo, S. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.533 · Cited by 322
Torbicki, A., Kurzyna, M., Kuca, P., Fijałkowska, A., Sikora, J., Florczyk, M., Pruszczyk, P., Burakowski, J., & Wawrzyńska, L. (2003) · Circulation · doi:10.1161/01.cir.0000084544.54513.e2 · Cited by 318
Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension
Jeffery, T. K., & Morrell, N. W. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.130041 · Cited by 317
Nootens, M., Kaufmann, E., Rector, T., Toher, C., Judd, D., Francis, G. S., & Rich, S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00399-1 · Cited by 317
Nunes, H., Humbert, M., Sitbon, O., Morse, J. H., Deng, Z., Knowles, J. A., Le Gall, C., Parent, F., Garcia, G., Hervé, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-330oc · Cited by 317
Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
Rubin, L. J., Groves, B. M., Reeves, J. T., Frosolono, M., Handel, F., & Cato, A. E. (1982) · Circulation · doi:10.1161/01.cir.66.2.334 · Cited by 316
Pulmonary Hypertension in Patients With End-Stage Renal Disease
Yigla, M., Nakhoul, F., Sabag, A., Tov, N., Gorevich, B., Abassi, Z., & Reisner, S. A. (2003) · Chest · doi:10.1378/chest.123.5.1577 · Cited by 316
Primary Pulmonary Hypertension and Cirrhosis: Are They Related? 1– 3
McDonnell, P. J., Toye, P. A., & Hutchins, G. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.4.437 · Cited by 315
Long-Term Outcome after Pulmonary Thromboendarterectomy
ARCHIBALD, C. J., AUGER, W. R., FEDULLO, P. F., CHANNICK, R. N., KERR, K. M., JAMIESON, S. W., KAPELANSKI, D. P., WATT, C. N., & MOSER, K. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9808109 · Cited by 315
ET A and ET B Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells
DAVIE, N., HALEEN, S. J., UPTON, P. D., POLAK, J. M., YACOUB, M. H., MORRELL, N. W., & WHARTON, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.3.2104059 · Cited by 314
Stasch, J., Schmidt, P., Alonso‐Alija, C., Apeler, H., Dembowsky, K., Haerter, M., Heil, M., Minuth, T., Perzborn, E., Pleiss, U., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704778 · Cited by 313
Hoeper, M. M., Olschewski, H., Ghofrani, H. A., Wilkens, H., Winkler, J., Borst, M. M., Niedermeyer, J., Fabel, H., & Seeger, W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00494-5 · Cited by 313
Pulmonary Hypertension Predicts Mortality and Morbidity in Patients with Dilated Cardiomyopathy
Abramson, S. V., Burke, J. F., Kelly, J. J., Kitchen, J. G., Dougherty, M. J., Yih, D. F., McGeehin, F. C., Shuck, J. W., & Phiambolis, T. P. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-11-888 · Cited by 312
Thrombotic risk factors in pulmonary hypertension
Wolf, M., Boyer-Neumann, C., Parent, F., Eschwege, V, Jaillet, H., Meyer, D., & Simonneau, G. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15b28.x · Cited by 310
Cool, C. D., Stewart, J. S., Werahera, P., Miller, G. J., Williams, R. L., Voelkel, N. F., & Tuder, R. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65137-1 · Cited by 309
Ghofrani, H. A., Reichenberger, F., Kohstall, M. G., Mrosek, E. H., Seeger, T., Olschewski, H., Seeger, W., & Grimminger, F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-3-200408030-00005 · Cited by 309
Pulmonary Arterial Hypertension
Chin, K. M., & Rubin, L. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.024 · Cited by 309
Humbert, M., Monti, G., Fartoukh, M., Magnan, A., Brenot, F., Rain, B., Capron, F., Galanaud, P., Duroux, P., Simonneau, G., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11030554 · Cited by 306
The natural history of ventricular septal defects in infancy
Hoffman, J. I. E., & Rudolph, A. M. (1965) · The American Journal of Cardiology · doi:10.1016/0002-9149(65)90047-0 · Cited by 303
Shapiro, S. M., Oudiz, R. J., Cao, T., Romano, M. A., Beckmann, X. J., Georgiou, D., Mandayam, S., Ginzton, L. E., & Brundage, B. H. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00187-3 · Cited by 303
Cowan, K. N., Jones, P. L., & Rabinovitch, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6539 · Cited by 302
Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells
Sakao, S., Taraseviciene‐Stewart, L., Lee, J. D., Wood, K., Cool, C. D., & Voelkel, N. F. (2005) · The FASEB Journal · doi:10.1096/fj.04-3261fje · Cited by 301
Sitbon, O., Humbert, M., Jagot, J., Taravella, O., Fartoukh, M., Parent, F., Herve, P., & Simonneau, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12020265 · Cited by 301
Pathobiology of Pulmonary Hypertension
Rabinovitch, M. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092033 · Cited by 301
Katz, S. D., Balidemaj, K., Homma, S., Wu, H., Wang, J., & Maybaum, S. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00790-7 · Cited by 300
Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography.
Auger, W. R., Fedullo, P. F., Moser, K. M., Buchbinder, M., & Peterson, K. L. (1992) · Radiology · doi:10.1148/radiology.182.2.1732955 · Cited by 300
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.
Opravil, M., Pechère, M., Speich, R., Joller-Jemelka, H. I., Jenni, R., Russi, E. W., Hirschel, B., & Lüthy, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.3.9117037 · Cited by 299
Little, W. C., Zile, M. R., Kitzman, D. W., Hundley, W. G., O'Brien, T. X., & deGroof, R. C. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.09.010 · Cited by 299
Left Ventricular Diastolic Dysfunction and Diastolic Heart Failure
Gaasch, W. H., & Zile, M. R. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104417 · Cited by 299
Attenuated K+ channel gene transcription in primary pulmonary hypertension
Yuan, X.-J., Wang, J., Juhaszova, M., Gaine, S. P., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78495-6 · Cited by 298
Pulmonary Veno-occlusive Disease
MANDEL, J., MARK, E. J., & HALES, C. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9912045 · Cited by 297
Eddahibi, S., Guignabert, C., Barlier-Mur, A.-M., Dewachter, L., Fadel, E., Dartevelle, P., Humbert, M., Simonneau, G., Hanoun, N., Saurini, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591321 · Cited by 297
Schulz, R. (2000) · Thorax · doi:10.1136/thorax.55.12.1046 · Cited by 297
Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
Chen, S. J., Chen, Y. F., Meng, Q. C., Durand, J., Dicarlo, V. S., & Oparil, S. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.6.2122 · Cited by 296
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension
Bonderman, D., Jakowitsch, J., Adlbrecht, C., Schemper, M., Kyrle, P., Schönauer, V., Exner, M., Klepetko, W., Kneussl, M., Maurer, G., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-10-0657 · Cited by 296
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
Provencher, S., Sitbon, O., Humbert, M., Cabrol, S., Jaïs, X., & Simonneau, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi728 · Cited by 296
Heart failure with a normal ejection fraction
Sanderson, J. E. (2007) · Heart · doi:10.1136/hrt.2005.074187 · Cited by 295
Results of European post-marketing surveillance of bosentan in pulmonary hypertension
Humbert, M., Segal, E. S., Kiely, D. G., Carlsen, J., Schwierin, B., & Hoeper, M. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00138706 · Cited by 295
Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension
Cool, C. D., Rai, P. R., Yeager, M. E., Hernandez-Saavedra, D., Serls, A. E., Bull, T. M., Geraci, M. W., Brown, K. K., Routes, J. M., Tuder, R. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035115 · Cited by 294
Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension
Tapson, V. F., Gomberg-Maitland, M., McLaughlin, V. V., Benza, R. L., Widlitz, A. C., Krichman, A., & Barst, R. J. (2006) · Chest · doi:10.1378/chest.129.3.683 · Cited by 294
Self-citationFukuta, H., Sane, D. C., Brucks, S., & Little, W. C. (2005) · Circulation · doi:10.1161/circulationaha.104.519876 · Cited by 294
Ockaili, R., Salloum, F., Hawkins, J., & Kukreja, R. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00324.2002 · Cited by 292
McKenna, S. P., Doughty, N., Meads, D. M., Doward, L. C., & Pepke-Zaba, J. (2006) · Quality of Life Research · doi:10.1007/s11136-005-3513-4 · Cited by 290
Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Chronic Heart Failure
Delgado, J. F., Conde, E., Sánchez, V., López-Ríos, F., Gómez-Sánchez, M. A., Escribano, P., Sotelo, T., de la Cámara, A. G., Cortina, J., & de la Calzada, C. S. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.10.021 · Cited by 289
Chemokine RANTES in Severe Pulmonary Arterial Hypertension
DORFMÜLLER, P., ZARKA, V., DURAND-GASSELIN, I., MONTI, G., BALABANIAN, K., GARCIA, G., CAPRON, F., COULOMB-LHERMINÉ, A., MARFAING-KOKA, A., SIMONNEAU, G., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.2012112 · Cited by 288
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Hoeper, M. M., Leuchte, H., Halank, M., Wilkens, H., Meyer, F. J., Seyfarth, H. J., Wensel, R., Ripken, F., Bremer, H., Kluge, S., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00057906 · Cited by 288
Sütsch, G., Kiowski, W., Yan, X.-W., Hunziker, P., Christen, S., Strobel, W., Kim, J.-H., Rickenbacher, P., & Bertel, O. (1998) · Circulation · doi:10.1161/01.cir.98.21.2262 · Cited by 287
Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension
Bonderman, D., Skoro-Sajer, N., Jakowitsch, J., Adlbrecht, C., Dunkler, D., Taghavi, S., Klepetko, W., Kneussl, M., & Lang, I. M. (2007) · Circulation · doi:10.1161/circulationaha.106.661041 · Cited by 286
Fukumoto, Y., Matoba, T., Ito, A., Tanaka, H., Kishi, T., Hayashidani, S., Abe, K., Takeshita, A., & Shimokawa, H. (2005) · Heart · doi:10.1136/hrt.2003.029470 · Cited by 286
Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial
Olschewski, H., Ghofrani, H. A., Schmehl, T., Winkler, J., Wilkens, H., Hoeper, M. M., Behr, J., Kleber, F. X., Seeger, W., & for the German PPH Study Group* (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00003 · Cited by 286
Ghofrani, H. A., Voswinckel, R., Reichenberger, F., Olschewski, H., Haredza, P., Karadaş, B., Schermuly, R. T., Weissmann, N., Seeger, W., & Grimminger, F. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.060 · Cited by 286
Yeager, M. E., Halley, G. R., Golpon, H. A., Voelkel, N. F., & Tuder, R. M. (2001) · Circulation Research · doi:10.1161/01.res.88.1.e2 · Cited by 286
Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease
Leuchte, H. H., Baumgartner, R. A., Nounou, M. E., Vogeser, M., Neurohr, C., Trautnitz, M., & Behr, J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1545oc · Cited by 284
Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H. A., SCHERMULY, R. T., Rose, F., Wiedemann, R., Kohstall, M. G., Kreckel, A., Olschewski, H., Weißmann, N., Enke, B., Ghofrani, S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1157bc · Cited by 283
Paciocco, G., Martinez, F. J., Bossone, E., Pielsticker, E., Gillespie, B., & Rubenfire, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17406470 · Cited by 283
Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32
Nichols, W. C., Koller, D. L., Slovis, B., Foroud, T., Terry, V. H., Arnold, N. D., Siemieniak, D. R., Wheeler, L., Phillips, J. A., Newman, J. H., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-277 · Cited by 281
Bossone, E., Rubenfire, M., Bach, D. S., Ricciardi, M., & Armstrong, W. F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00055-8 · Cited by 277
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275
Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney
Dousa, T. P. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00233.x · Cited by 274
The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia
Halcox, J. P. J., Nour, K. R. A., Zalos, G., Mincemoyer, R., Waclawiw, M. A., Rivera, C. E., Willie, G., Ellahham, S., & Quyyumi, A. A. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02139-3 · Cited by 274
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Balabanian, K., Foussat, A., Dorfmüller, P., Durand-Gasselin, I., Capel, F., Bouchet-Delbos, L., Portier, A., Marfaing-Koka, A., Krzysiek, R., Rimaniol, A.-C., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106007 · Cited by 274
Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase
Soderling, S. H., Bayuga, S. J., & Beavo, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8991 · Cited by 271
Incidence of Pulmonary Hypertension and Its Clinical Relevance in Patients With Sarcoidosis
Handa, T., Nagai, S., Miki, S., Fushimi, Y., Ohta, K., Mishima, M., & Izumi, T. (2006) · Chest · doi:10.1378/chest.129.5.1246 · Cited by 270
Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension
Hoeper, M. M., Faulenbach, C., Golpon, H., Winkler, J., Welte, T., & Niedermeyer, J. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00051104 · Cited by 268
Severe Osteoporosis Before and After Lung Transplantation
Aris, R. M., Neuringer, I. P., Weiner, M. A., Egan, T. M., & Ontjes, D. (1996) · Chest · doi:10.1378/chest.109.5.1176 · Cited by 267
Geraci, M. W., Moore, M., Gesell, T., Yeager, M. E., Alger, L., Golpon, H., Gao, B., Loyd, J. E., Tuder, R. M., & Voelkel, N. F. (2001) · Circulation Research · doi:10.1161/01.res.88.6.555 · Cited by 267
Endothelial Progenitor Cells: New Hope for a Broken Heart
Szmitko, P. E., Fedak, P. W. M., Weisel, R. D., Stewart, D. J., Kutryk, M. J. B., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000074242.66719.4a · Cited by 267
Castro, M., Krowka, M. J., Schroeder, D. R., Beck, K. C., Plevak, D. J., Rettke, S. R., Cortese, D. A., & Wiesner, R. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.6.543 · Cited by 266
Pathogenic mechanisms of pulmonary arterial hypertension
Chan, S. Y., & Loscalzo, J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.09.006 · Cited by 265
Oudiz, R. J., Schilz, R. J., Barst, R. J., Galié, N., Rich, S., Rubin, L. J., & Simonneau, G. (2004) · Chest · doi:10.1378/chest.126.2.420 · Cited by 264
Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension
Rosenzweig, E. B., Ivy, D. D., Widlitz, A., Doran, A., Claussen, L. R., Yung, D., Abman, S. H., Morganti, A., Nguyen, N., & Barst, R. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.066 · Cited by 264
Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039438 · Cited by 263
Cool, C. D., Kennedy, D., Voelkel, N. F., & Tuder, R. M. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90032-0 · Cited by 263
Singh, T. P., Rohit, M., Grover, A., Malhotra, S., & Vijayvergiya, R. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.09.006 · Cited by 263
Pulmonary Hypertension: CT of the Chest in Pulmonary Venoocclusive Disease
Resten, A., Maitre, S., Humbert, M., Rabiller, A., Sitbon, O., Capron, F., Simonneau, G., & Musset, D. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.183.1.1830065 · Cited by 263
Donovan, C. L., Marcovitz, P. A., Punch, J. D., Bach, D. S., Brown, K. A., Lucey, M. R., & Armstrong, W. F. (1996) · Transplantation · doi:10.1097/00007890-199604270-00011 · Cited by 263
West, J., Fagan, K., Steudel, W., Fouty, B., Lane, K., Harral, J., Hoedt-Miller, M., Tada, Y., Ozimek, J., Tuder, R., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126047.82846.20 · Cited by 263
Pharmacology of phosphodiesterase inhibitors
(2005) · Therapeutic Strategies in COPD · doi:10.1201/b14809-12 · Cited by 261
Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension
Sebkhi, A., Strange, J. W., Phillips, S. C., Wharton, J., & Wilkins, M. R. (2003) · Circulation · doi:10.1161/01.cir.0000074226.20466.b1 · Cited by 261
Autoimmunity and pulmonary hypertension: a perspective
Nicolls, M. R., Taraseviciene-Stewart, L., Rai, P. R., Badesch, D. B., & Voelkel, N. F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00045705 · Cited by 261
Primary pulmonary hypertension
Walcott, G., Burchell, H. B., & Brown, A. L. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80115-2 · Cited by 260
Pozeg, Z. I., Michelakis, E. D., McMurtry, M. S., Thébaud, B., Wu, X.-C., Dyck, J. R. B., Hashimoto, K., Wang, S., Moudgil, R., Harry, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000062688.76508.b3 · Cited by 260
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension
Bonderman, D., Turecek, P., Jakowitsch, J., Weltermann, A., Adlbrecht, C., Schneider, B., Kneussl, M., Rubin, L., Kyrle, P., Klepetko, W., et al. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0067 · Cited by 259
Sitbon, O., Gressin, V., Speich, R., Macdonald, P. S., Opravil, M., Cooper, D. A., Fourme, T., Humbert, M., Delfraissy, J.-F., & Simonneau, G. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-445oc · Cited by 259
HOEPER, M. M., MAIER, R., TONGERS, J., NIEDERMEYER, J., HOHLFELD, J. M., HAMM, M., & FABEL, H. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9811062 · Cited by 256
Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats
SCHERMULY, R. T., Kreisselmeier, K. P., Ghofrani, H. A., Yilmaz, H., BUTROUS, G. S., Ermert, L., Ermert, M., Weißmann, N., Rose, F., Guenther, A., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-282oc · Cited by 256
Galiè, N., Seeger, W., Naeije, R., Simonneau, G., & Rubin, L. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.038 · Cited by 255
Technique of Successful Clinical Double-Lung Transplantation
Patterson, G. A., Cooper, J. D., Goldman, B., Weisel, R. D., Pearson, F. G., Waters, P. F., Todd, T. R., Scully, H., Goldberg, M., & Ginsberg, R. J. (1988) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)64763-7 · Cited by 255
Grünig, E., Janssen, B., Mereles, D., Barth, U., Borst, M. M., Vogt, I. R., Fischer, C., Olschewski, H., Kuecherer, H. F., & Kübler, W. (2000) · Circulation · doi:10.1161/01.cir.102.10.1145 · Cited by 255
Blade Balloon Atrial Septostomy in Patients With Severe Primary Pulmonary Hypertension
Kerstein, D., Levy, P. S., Hsu, D. T., Hordof, A. J., Gersony, W. M., & Barst, R. J. (1995) · Circulation · doi:10.1161/01.cir.91.7.2028 · Cited by 255
A new role for an old molecule: serotonin as a mitogen
Fanburg, B. L., & Lee, S. L. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.5.l795 · Cited by 255
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension.
Loyd, J. E., Butler, M. G., Foroud, T. M., Conneally, P. M., Phillips, J. A., & Newman, J. H. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599869 · Cited by 254
Primary Pulmonary Hypertension: A Histopathologic Study of 80 Cases
BJORNSSON, J., & EDWARDS, W. D. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65277-x · Cited by 253
Nishimura, T., Vaszar, L. T., Faul, J. L., Zhao, G., Berry, G. J., Shi, L., Qiu, D., Benson, G., Pearl, R. G., & Kao, P. N. (2003) · Circulation · doi:10.1161/01.cir.0000087592.47401.37 · Cited by 251
End Points and Clinical Trial Design in Pulmonary Arterial Hypertension
McLaughlin, V. V., Badesch, D. B., Delcroix, M., Fleming, T. R., Gaine, S. P., Galiè, N., Gibbs, J. S. R., Kim, N. H., Oudiz, R. J., Peacock, A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.007 · Cited by 251
Self-citationChaouat, A. (2004) · Thorax · doi:10.1136/thx.2003.11890 · Cited by 250
Severe Pulmonary Hypertension in Histiocytosis X
FARTOUKH, M., HUMBERT, M., CAPRON, F., MAÎTRE, S., PARENT, F., LE GALL, C., SITBON, O., HERVÉ, P., DUROUX, P., & SIMONNEAU, G. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9807024 · Cited by 248
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Patel, N. M., Lederer, D. J., Borczuk, A. C., & Kawut, S. M. (2007) · Chest · doi:10.1378/chest.06-3087 · Cited by 248
Genetic basis of pulmonary arterial hypertension
Newman, J. H., Trembath, R. C., Morse, J. A., Grunig, E., Loyd, J. E., Adnot, S., Coccolo, F., Ventura, C., Phillips, J. A., Knowles, J. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.028 · Cited by 247
Davie, N. J., Crossno, J. T., Frid, M. G., Hofmeister, S. E., Reeves, J. T., Hyde, D. M., Carpenter, T. C., Brunetti, J. A., McNiece, I. K., & Stenmark, K. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00108.2003 · Cited by 247
Gatzoulis, M. A., Beghetti, M., Galiè, N., Granton, J., Berger, R. M. F., Lauer, A., Chiossi, E., & Landzberg, M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.078 · Cited by 246
Sildenafil Inhibits Altitude-induced Hypoxemia and Pulmonary Hypertension
Richalet, J.-P., Gratadour, P., Robach, P., Pham, I., Déchaux, M., Joncquiert-Latarjet, A., Mollard, P., Brugniaux, J., & Cornolo, J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-804oc · Cited by 245
Merklinger, S. L., Jones, P. L., Martinez, E. C., & Rabinovitch, M. (2005) · Circulation · doi:10.1161/circulationaha.105.540542 · Cited by 245
Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1
Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01256.x · Cited by 243
Lantuéjoul, S., Sheppard, M. N., Corrin, B., Burke, M. M., & Nicholson, A. G. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000209834.69972.e5 · Cited by 243
Hypoxia, HIF-1, and the Pathophysiologi of Common Human Diseases
Semenza, G. L., Agani, F., Feldser, D., Lyer, N., Kotch, L., Laughner, E., & Yu, 1. (2006) · Advances in Experimental Medicine and Biology · doi:10.1007/0-306-46825-5_12 · Cited by 241
Barst, R. J., Rich, S., Widlitz, A., Horn, E. M., McLaughlin, V., & McFarlin, J. (2002) · Chest · doi:10.1378/chest.121.6.1860 · Cited by 241
Self-citationTransforming Growth Factor-β Receptor Mutations and Pulmonary Arterial Hypertension in Childhood
Harrison, R. E., Berger, R., Haworth, S. G., Tulloh, R., Mache, C. J., Morrell, N. W., Aldred, M. A., & Trembath, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000153798.78540.87 · Cited by 241
Brett, K. M., & Madans, J. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009142 · Cited by 241
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
Williams, M. H. (2006) · Heart · doi:10.1136/hrt.2005.069484 · Cited by 237
Inhaled Rho Kinase Inhibitors Are Potent and Selective Vasodilators in Rat Pulmonary Hypertension
Nagaoka, T., Fagan, K. A., Gebb, S. A., Morris, K. G., Suzuki, T., Shimokawa, H., McMurtry, I. F., & Oka, M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-637oc · Cited by 235
CONTINUOUS INTRAVENOUS INFUSION OF EPOPROSTENOL FOR THE TREATMENT OF PORTOPULMONARY HYPERTENSION1
Kuo, P. C., Johnson, L. B., Plotkin, J. S., Howell, C. D., Bartlett, S. T., & Rubin, L. J. (1997) · Transplantation · doi:10.1097/00007890-199702270-00020 · Cited by 234
Eddahibi, S., Chaouat, A., Morrell, N., Fadel, E., Fuhrman, C., Bugnet, A.-S., Dartevelle, P., Housset, B., Hamon, M., Weitzenblum, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091409.53101.e8 · Cited by 234
Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension
McLaughlin, V. V., Gaine, S. P., Barst, R. J., Oudiz, R. J., Bourge, R. C., Frost, A., Robbins, I. M., Tapson, V. F., McGoon, M. D., Badesch, D. B., et al. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200302000-00019 · Cited by 232
Self-citationMacLean, M. R., Herve, P., Eddahibi, S., & Adnot, S. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703570 · Cited by 232
Macchia, A., Marchioli, R., Marfisi, R., Scarano, M., Levantesi, G., Tavazzi, L., & Tognoni, G. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.02.037 · Cited by 232
Pearson, D. L., Dawling, S., Walsh, W. F., Haines, J. L., Christman, B. W., Bazyk, A., Scott, N., & Summar, M. L. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106143442404 · Cited by 229
Prostanoid therapy for pulmonary arterial hypertension
Badesch, D. B., McLaughlin, V. V., Delcroix, M., Vizza, C. D., Olschewski, H., Sitbon, O., & Barst, R. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.036 · Cited by 228
Self-citationSplenectomy and chronic thromboembolic pulmonary hypertension
Jais, X. (2005) · Thorax · doi:10.1136/thx.2004.038083 · Cited by 228
Geraci, M. W., Gao, B., Shepherd, D. C., Moore, M. D., Westcott, J. Y., Fagan, K. A., Alger, L. A., Tuder, R. M., & Voelkel, N. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5911 · Cited by 227
Cited by
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Self-citationChanges in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Metadata
- Authors
- McLaughlin, V. V., & McGoon, M. D.
- Venue
- Circulation
- Published
- 2006-09-26
- Volume
- 114
- Issue
- 13
- Pages
- 1417-1431
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2170331970
- Cited by
- 664
- References
- 800
- FWCI
- 39.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.